Medinews - Medical News, Articles and Blogs

Advertisement
CV Therapeutics, Inc. (Nasdaq: CVTX) announced today that two late breaking clinical trials, including the MERLIN TIMI-36 study and a regadenoson trial, and six other abstracts have been accepted for presentation at the American College of Cardiology (ACC) Annual Scientific Session March 24-27, 2007... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Patients with coronary heart disease who took Lipitor(R) (atorvastatin calcium) 80 mg tablets reduced their risk of hospitalizations due to heart failure compared to patients taking the 10 mg dose of Lipitor, according to a new analysis of a subset of patients from the five-year TNT (Treating to New... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Aida Pharmaceuticals, Inc. (OTCBB: AIDA), one of Mainland China's leading pharmaceutical companies, today announced Company researchers have published an article entitled "Phase I Clinical Trial of Recombinant Human Apo-2 Ligand (Rh-Apo2L) in Patients with Advanced Cancer," in one of Mainland China... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Sanofi-aventis announced today the Food and Drug Administration (FDA) has accepted for review a supplemental new drug application (sNDA) for the anticoagulant Lovenox(R) (enoxaparin sodium injection) for the treatment of patients with acute ST-segment elevation myocardial infarction (STEMI), a type... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Neuroblastoma is a form of cancer that develops in the nervous system and it affects small children more commonly than any other tumour type. Now, however, scientists at Karolinska Institutet in Sweden can show that a common painkiller can inhibit the development of neuroblastoma and help make treat... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Physicians who treat a blood disorder called idiopathic thrombocytopenic purpura (ITP), characterized by easy bruising and excessive bleeding, now have a new tool to help them provide the best care for patients with this disease. This Web-based performance evaluation tool is the first non-malignan... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
ViroPharma Incorporated (Nasdaq: VPHM) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for maribavir for prevention of cytomegalovirus (CMV) viremia and disease in the populations at-risk. The Orphan Drug Act was designed to provide incentives to... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
The Society for Cardiovascular Angiography and Interventions (SCAI), a leading organization for interventional cardiologists, has released a document recommending the adoption of stringent quality standards by those who perform percutaneous coronary intervention (PCI) in hospitals not equipped for c... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
An international team of engineers led by Lehigh Prof. Arup SenGupta has won a $200,000 prize for its efforts to counter what some people have called the world's worst environmental catastrophe.The researchers, who have designed a system that filters arsenic from well water, will receive the Silver ... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury